Manufacturing news briefs – stories you might have missed
IDT Australia’s strong year as it develops mRNA technologies Independent pharmaceutical manufacturer IDT Australia has reported revenues up 74 per cent in the first half FY 22 to $8.56 million as its developed its capabilities in sterile manufacturing. Profit after tax was $1.21 million, up slightly from $1.12 million in the previous corresponding period. During…
Details